Anika Therapeutics's market cap is currently $238.87M. The company's EPS TTM is $-6.64; its P/E ratio is ―; Anika Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 166.66M	$ 156.24M	$ 147.79M	$ 130.46M	$ 114.61M
Gross Profit	$ 103.09M	$ 93.58M	$ 82.94M	$ 69.03M	$ 85.86M
Operating Income	$ -87.64M	$ -19.40M	$ -18.48M	$ -14.47M	$ 34.25M
EBITDA	$ -11.23M	$ -4.91M	$ 2.62M	$ -12.83M	$ 34.25M
Net Income	$ -82.67M	$ -14.86M	$ 4.13M	$ -23.98M	$ 27.19M
Balance Sheet
Cash & Short-Term Investments	$ 72.87M	$ 86.33M	$ 94.39M	$ 98.32M	$ 184.94M
Total Assets	$ 270.63M	$ 349.13M	$ 347.54M	$ 365.61M	$ 330.71M
Total Debt	$ 29.04M	$ 30.89M	$ 19.24M	$ 20.88M	$ 21.37M
Net Debt	$ -43.83M	$ -55.44M	$ -75.15M	$ -74.94M	$ -136.10M
Total Liabilities	$ 58.37M	$ 63.56M	$ 60.45M	$ 93.20M	$ 42.33M
Stockholders' Equity	$ 212.26M	$ 285.56M	$ 287.08M	$ 272.40M	$ 288.38M
Cash Flow
Free Cash Flow	$ -7.21M	$ -3.08M	$ 3.25M	$ 11.44M	$ 34.18M
Operating Cash Flow	$ -1.79M	$ 4.41M	$ 8.40M	$ 13.06M	$ 37.01M
Investing Cash Flow	$ -5.43M	$ -7.49M	$ -3.12M	$ -71.26M	$ 39.69M
Financing Cash Flow	$ -6.32M	$ -4.85M	$ -6.78M	$ -3.77M	$ -8.14M

Currency in USD

Anika Therapeutics Earnings and Revenue History

Income Statement >

Anika Therapeutics Debt to Assets

Balance Sheet >

Anika Therapeutics Cash Flow

Cash Flow >

Anika Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing